This strain contains 53 protein-level mutations:
We identified all possible linear viral peptides affected by these mutations. Whenever it was possible, we matched the reference peptide with the mutated one. For example, D -> L mutation transformed SDNGPQNQR to SLNGPQNQR. Cases when it was not meaningful included deletions and insertions at the flanks of the peptide, e.g., HV deletion in NVTWFHAIHV peptide.
Then, we predicted binding affinities between the selected peptides and frequent HLA alleles. Predictions were made with NetMHCpan-4.1 and NetMHCIIpan-4.0. The binding affinities were classifies into three groups:
Here we report HLA-peptide interactions whose affinity was altered by at least two folds. Note that mutations with empty set of altered interactions are not showed.
Weaker binding was found for 32 epitopes, while stronger binding was found for 24 entries. There are 268 tight binders for the HLA-A*11:01 in the reference immunopeptidome (IC50 affinity ≤ 50 nM); 13 of them became non-tight binders (4.8%) and 5 novel tight binders appeared (1.9%). To avoid possible divisions by zero, we used + 1 regularization term in denominators when calculating percentages.
Reference LLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCT
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated LLIVNNATNVVIKVCEFQFCNDPFLDVYYHKNNKSWMESEFRVYSSANNCT
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | GVYYHKNNK | DVYYHKNNK | 51 | 1768 |
Reference RFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVY
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated RFASVYAWNRKRISNCVADYSVLYNFAPFFAFKCYGVSPTKLNDLCFTNVY
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | LYNSASFSTFK | LYNFAPFFAFK | 43 | 797 |
HLA-A*11:01 | NSASFSTFK | NFAPFFAFK | 9 | 94 |
HLA-A*11:01 | SASFSTFK | FAPFFAFK | 452 | 1795 |
HLA-A*11:01 | YNSASFSTFK | YNFAPFFAFK | 12 | 38 |
HLA-A*11:01 | VLYNSASFSTFK | VLYNFAPFFAFK | 22 | 51 |
Reference ASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYAD
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated ASVYAWNRKRISNCVADYSVLYNFAPFFAFKCYGVSPTKLNDLCFTNVYAD
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | ASFSTFKCY | APFFAFKCY | 379 | 12606 |
HLA-A*11:01 | LYNSASFSTFK | LYNFAPFFAFK | 43 | 797 |
HLA-A*11:01 | NSASFSTFK | NFAPFFAFK | 9 | 94 |
HLA-A*11:01 | SASFSTFK | FAPFFAFK | 452 | 1795 |
HLA-A*11:01 | YNSASFSTFK | YNFAPFFAFK | 12 | 38 |
HLA-A*11:01 | VLYNSASFSTFK | VLYNFAPFFAFK | 22 | 51 |
Reference VYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFV
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated VYAWNRKRISNCVADYSVLYNFAPFFAFKCYGVSPTKLNDLCFTNVYADSFV
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | STFKCYGVSPTK | FAFKCYGVSPTK | 25 | 1030 |
HLA-A*11:01 | ASFSTFKCY | APFFAFKCY | 379 | 12606 |
HLA-A*11:01 | LYNSASFSTFK | LYNFAPFFAFK | 43 | 797 |
HLA-A*11:01 | FSTFKCYGVSPTK | FFAFKCYGVSPTK | 426 | 5482 |
HLA-A*11:01 | NSASFSTFK | NFAPFFAFK | 9 | 94 |
HLA-A*11:01 | SASFSTFK | FAPFFAFK | 452 | 1795 |
HLA-A*11:01 | YNSASFSTFK | YNFAPFFAFK | 12 | 38 |
HLA-A*11:01 | VLYNSASFSTFK | VLYNFAPFFAFK | 22 | 51 |
Reference SPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCV
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated SPTKLNDLCFTNVYADSFVIRGNEVSQIAPGQTGNIADYNYKLPDDFTGCV
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | RQIAPGQTGK | SQIAPGQTGN | 103 | 32387 |
Reference FTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLD
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated FTNVYADSFVIRGNEVSQIAPGQTGNIADYNYKLPDDFTGCVIAWNSNKLD
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | RQIAPGQTGK | SQIAPGQTGN | 103 | 32387 |
HLA-A*11:01 | QIAPGQTGK | QIAPGQTGN | 165 | 32767 |
Reference TGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFE
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated TGNIADYNYKLPDDFTGCVIAWNSNKLDSKVGGNYNYRYRLFRKSNLKPFE
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | CVIAWNSNN | CVIAWNSNK | 24486 | 26 |
HLA-A*11:01 | GCVIAWNSNN | GCVIAWNSNK | 32767 | 94 |
HLA-A*11:01 | TGCVIAWNSNN | TGCVIAWNSNK | 32767 | 153 |
HLA-A*11:01 | FTGCVIAWNSNN | FTGCVIAWNSNK | 32767 | 408 |
Reference DDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGS
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated DDFTGCVIAWNSNKLDSKVGGNYNYRYRLFRKSNLKPFERDISTEIYQAGN
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | KVGGNYNYL | KVGGNYNYR | 16150 | 194 |
HLA-A*11:01 | LYRLFRKSNLK | RYRLFRKSNLK | 952 | 401 |
Reference LYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGV
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated RYRLFRKSNLKPFERDISTEIYQAGNKPCNGVAGVNCYFPLQSYGFRPTYGV
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | STEIYQAGST | STEIYQAGNK | 30358 | 67 |
Reference YQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPAT
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated YQAGNKPCNGVAGVNCYFPLQSYGFRPTYGVGHQPYRVVVLSFELLHAPAT
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | QSYGFQPTN | QSYGFRPTY | 22068 | 301 |
Reference GSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCG
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated GNKPCNGVAGVNCYFPLQSYGFRPTYGVGHQPYRVVVLSFELLHAPATVCG
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | QSYGFQPTN | QSYGFRPTY | 22068 | 301 |
Reference EHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENS
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated EYVNNSYECDIPIGAGICASYQTQTKSHRRARSVASQSIIAYTMSLGAENS
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | CASYQTQTN | CASYQTQTK | 32767 | 431 |
HLA-A*11:01 | ASYQTQTNSPR | ASYQTQTKSHR | 346 | 1426 |
Reference VNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVA
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated VNNSYECDIPIGAGICASYQTQTKSHRRARSVASQSIIAYTMSLGAENSVA
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | ASYQTQTNSPR | ASYQTQTKSHR | 346 | 1426 |
Reference TMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIY
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated TMYICGDSTECSNLLLQYGSFCTQLKRALTGIAVEQDKNTQEVFAQVKQIY
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | LQYGSFCTQLN | LQYGSFCTQLK | 32767 | 191 |
HLA-A*11:01 | YGSFCTQLN | YGSFCTQLK | 32767 | 386 |
Reference ALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQID
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated ALGKLQDVVNHNAQALNTLVKQLSSKFGAISSVLNDILSRLDKVEAEVQID
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | TLVKQLSSN | TLVKQLSSK | 32767 | 125 |
HLA-A*11:01 | NTLVKQLSSN | NTLVKQLSSK | 32767 | 147 |
Reference GGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQ
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated GGSQASSRSSSRSRNSSRNSTPGSSKRTSPARMAGNGGDAALALLLLDRLNQ
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | SSRNSTPGSSR | SSRNSTPGSSK | 2231 | 263 |
Reference DPKISEMHPALRLVDPQIQLAVTRMENAVGRDQNNVGPKVYPIILRLGSPLSL
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated DPKISEMHSALRLVDPQIQLAVTRM‑‑‑VGRDQNNVGPKVYPIILRLGSPLSL
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | VTRMENAVGR | VTRMVGR | 268 | - |
Reference APTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTE
||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated APTKVTFGDDTVIEVQGYKSVNIIFELDERIDKVLNEKCSAYTVELGTE
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | ITFELDERIDK | IIFELDERIDK | 446 | 1259 |
Reference DAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQ
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated DAPYIVGDVVQEGVLTAVVIPTKKASGTTEMLAKALRKVPTDNYITTYPGQ
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | AGGTTEMLAK | ASGTTEMLAK | 1254 | 37 |
HLA-A*11:01 | KAGGTTEMLAK | KASGTTEMLAK | 589 | 203 |
Reference QPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCV
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated QPGQTFSVLACYNGSPSGVYQCAMRHNFTIKGSFLNGSCGSVGFNIDYDCV
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | AMRPNFTIK | AMRHNFTIK | 175 | 376 |
HLA-A*11:01 | CAMRPNFTIK | CAMRHNFTIK | 42 | 88 |
Reference FNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYD
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated FNMVYMPASWVMRIMTWLDMVDTSL‑‑‑KLKDCVMYASAVVLLILMTARTVYD
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | MVDTSLSGFK | MVDTSLK | 21 | - |
HLA-A*11:01 | TSLSGFKLK | TSLKLK | 22 | - |
HLA-A*11:01 | MTWLDMVDTSLSGFK | MTWLDMVDTSLK | - | 71 |
HLA-A*11:01 | RIMTWLDMVDTSLSGFK | RIMTWLDMVDTSLK | - | 128 |
HLA-A*11:01 | DTSLSGFKLK | DTSLKLK | 488 | - |
HLA-A*11:01 | WLDMVDTSLSGFK | WLDMVDTSLK | 4020 | 492 |
HLA-A*11:01 | MVDTSLSGFKLK | MVDTSLKLK | 143 | 50 |
Reference CVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHF
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated CVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHF
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | PTSFGPLVR | LTSFGPLVR | 4068 | 379 |
HLA-A*11:01 | PTSFGPLVRK | LTSFGPLVRK | 123 | 21 |
Reference TADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTL
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated TADIVVFDEISMATNYDLSVVNARLCAKHYVYIGDPAQLPAPRTLLTKGTL
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*11:01 | VVNARLRAK | VVNARLCAK | 145 | 44 |